STE STE

Name: STE Crucible Score
Creator: Kaladin Capital Intelligence

UnknownUnknownN/A📅 Scored March 19, 2026

Price at analysis: $223.90

Crucible Score

63.4

B-

Quality × Value Composite

KQI — Quality

67.6

B-

Fundamental Quality Index

KVI — Value

58.4

Valuation Attractiveness Index

Crucible Verdict — STE

STE earns a solid B- grade with strong fundamentals overshadowed by valuation concerns and insider selling pressure. The company demonstrates robust financial quality (74) and growth prospects (73), but trades at a meaningful discount to fair value despite a 70% earnings beat rate. The persistent insider selling activity suggests management lacks confidence in near-term catalysts to close the 11% valuation gap.

— Kal, Kaladin Capital Intelligence

◆ KQI Quality Dimensions

Financial Quality

74.2

Growth Profile

73.0

Moat Durability

66.3

Management Effectiveness

60.8

Diversification & Resilience⚠

54.0

Market Position

68.0

Weakest dimension: Diversification & Resilience (54.0)

◆ KVI Value Dimensions

DCF Margin of Safety

64.6

FCF Yield & Cash Returns

38.3

Relative Valuation

53.3

Growth-Adjusted Value

65.0

Historical Valuation

86.4

Macro Context

42.6

◆ DCF Valuation Scenarios

Bear Case

$175.42

Base Case

$248.63

Bull Case

$341.18

Price at Analysis

$223.90

Scenario	Fair Value	Rev CAGR (5yr)	Terminal Margin	WACC
🔴 Bear	$175.42	4.0%	14.0%	9.8%
🟢 Base	$248.63	6.0%	16.0%	9.3%
🟢 Bull	$341.18	8.0%	18.0%	8.8%

Key Assumptions: Revenue grew from ~$3.1B to ~$5.5B over 5 years (~12% CAGR) driven by acquisitions; organic growth likely 4-8%. Operating margins have ranged 11-18% with recent normalization around 16%; capex intensity ~6.8% of revenue reflects device manufacturing needs. WACC uses 5.5% ERP given healthcare sector stability, with bear/base/bull spreads of +/-50bps. Net debt of ~$2.0B deducted from enterprise value across all scenarios.

◆ Financial Snapshot

Profitability

Gross Margin44.1%

Operating Margin17.2%

Net Margin12.1%

ROIC8.6%

ROE9.9%

Balance Sheet

Balance SheetD/E: 0.29*, CR: 2.48* (* = TTM)

Cash ConversionFCF/EPS: 1.30x

Capital IntensityCapex/Rev: 6.8%

Altman Z-Score5.13 (Safe)

Piotroski F-Score8/9 (Strong)

Growth

Revenue CAGR15.1% CAGR

Earnings CAGR11.5% CAGR

Growth ConsistencyCV: 0.93

Segment Breadth2/2 growing (100%)

Quarterly TrendRev∆, Margin↓↓, WC↓

Earnings CredibilityTends to Beat

◆ Analyst Consensus & Leadership

Leadership & Governance

CEO Ownership1.1%

Compensation88% performance-based

Insider ActivitySelling

Capital AllocationROIC 8.6% vs WACC 3.1%

Earnings Beat Rate70% (15/22)

◆ Related Companies in Our Universe

Other Unknown companies scored by the Crucible:

ADBE81.8A-NICE80.7A-DECK79.9A-INTU79.9A-EXEL78.3A-MTCH78.2A-TTD78.0B+

Methodology All Scores Crucible Briefs Performance @KaladinCI

Analysis conducted March 19, 2026 based on most recent SEC filings. Updated quarterly, after new SEC filings.

Point-in-time fundamental analysis. Not investment advice. Scores reflect company quality and valuation at time of analysis and may not reflect current market conditions.